Seek urgent help for facial swelling, breathing difficulties, or rapidly spreading rashes
773, no
Sri Lanka Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market (2026-2032) | Share, Outlook, Analysis, Growth, Value, Forecast, Industry, Companies, Size & Revenue, Segmentation, Competitive Landscape, Trends Market Forecast By GLP-1 Receptor Agonists (Exenatide, Liraglutide (Victoza), Lixisenatide (Lyxumia), Dulaglutide (Trulicity), Semaglutide (Ozempic)), By Insulin Drugs (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, Biosimilar Insulins) And Competitive Landscape Sri Lanka import trend for insulin drugs and GLP-1 receptor agonists showed significant growth, with a 43.03% increase from 2023 to 2024
For weight management, specific criteria apply as outlined in relevant NICE technology appraisals (such as TA875 for semaglutide 2.4mg), generally requiring a BMI 35 kg/m (or 30 kg/m with weight-related comorbidities), with lower thresholds (typically 2.5 kg/m lower) for people from certain ethnic groups, and treatment within specialist weight management services
Vitamin injections may be right for you if you are tired, stressed out, unable to sleep or have been exposed to people who are sick
Overall, semaglutide GLP-1 injections offer significant benefits by regulating blood sugar levels, promoting weight loss, and improving overall health outcomes for patients with type 2 diabetes and obesity
